{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:42:05Z","timestamp":1790484125263,"version":"4.1.0"},"reference-count":253,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Instituto de Salud Carlos III, Subdirecci\u00f3n General de Redes y Centros de Investigaci\u00f3n Cooperativa, Ministerio de Econom\u00eda y Competitividad, Spanish Network for Research in Infectious Diseases"},{"name":"European Development Regional Fund"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.eimc.2015.03.015","type":"journal-article","created":{"date-parts":[[2015,5,3]],"date-time":"2015-05-03T00:55:03Z","timestamp":1430614503000},"page":"625.e1-625.e23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)"],"prefix":"10.1016","volume":"33","author":[{"given":"Francesc","family":"Gudiol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benito","family":"Almirante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Bouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Cercenado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. \u00c1ngeles","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Gasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Lora-Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Palomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Pericas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Rodr\u00edguez-Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Vall\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2015.03.015_bib1000","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1469-0691.2012.03903.x","article-title":"The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study","volume":"19","author":"Laupland","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib1005","doi-asserted-by":"crossref","first-page":"O630","DOI":"10.1111\/1469-0691.12564","article-title":"Case fatality ratio and mortality rate trends of community-onset Staphylococcus aureus bacteraemia","volume":"20","author":"Tom","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib1010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jama.2012.7139","article-title":"Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005\u20132010","volume":"308","author":"Landrum","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2015.03.015_bib1015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1469-0691.1997.tb00617.x","article-title":"Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990","volume":"3","author":"Frimodt-Moller","year":"1997","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib1020","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2006.05.016","article-title":"Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003","volume":"48","author":"Voigt","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.eimc.2015.03.015_bib1025","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/1469-0691.12108","article-title":"Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy","volume":"19","author":"Gasch","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib1030","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1001\/jama.2014.6364","article-title":"Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis","volume":"312","author":"Kalil","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2015.03.015_bib1035","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3201\/eid\/1706.101037","article-title":"High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia","volume":"17","author":"Aguado","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/jir270","article-title":"Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations","volume":"204","author":"Holmes","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1045","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/jac\/dks128","article-title":"Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients","volume":"67","author":"Rojas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.eimc.2008.09.003","article-title":"Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica","volume":"27","author":"Gudiol","year":"2009","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2015.03.015_bib1055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinids\/18.3.421","article-title":"Purpose of quality standards for infectious diseases. Infectious Diseases Society of America","volume":"18","author":"Gross","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1060","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1309\/AJCPVMDQU2ZJDPBL","article-title":"Decreased mortality associated with prompt Gram staining of blood cultures","volume":"130","author":"Barenfanger","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.eimc.2015.03.015_bib1065","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/1469-0691.12329","article-title":"Matrix-assisted laser desorption ionization time-of-flight mass spectrometry and PCR-based rapid diagnosis of Staphylococcus aureus bacteraemia","volume":"20","author":"Clerc","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib1070","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.diagmicrobio.2014.01.001","article-title":"A cost-saving algorithm for rapid diagnosis of Staphylococcus aureus and susceptibility to oxacillin directly from positive blood culture bottles by combined testing with BinaxNOW(R) S. aureus and Xpert MRSA\/SA Assay","volume":"78","author":"Yossepowitch","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1075","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1128\/JCM.01831-09","article-title":"Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry fingerprinting","volume":"48","author":"Christner","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2015.03.015_bib1080","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1128\/JCM.01087-13","article-title":"Evaluation of the BinaxNOW Staphylococcus aureus test for rapid identification of Gram-positive cocci from VersaTREK blood culture bottles","volume":"51","author":"Dhiman","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2015.03.015_bib1085","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/1615-9861(200206)2:6<747::AID-PROT747>3.0.CO;2-V","article-title":"Identification and discrimination of Staphylococcus aureus strains using matrix-assisted laser desorption\/ionization-time of flight mass spectrometry","volume":"2","author":"Bernardo","year":"2002","journal-title":"Proteomics"},{"key":"10.1016\/j.eimc.2015.03.015_bib1090","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1021\/ac020109k","article-title":"Identification of Staphylococcus aureus and determination of its methicillin resistance by matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry","volume":"74","author":"Du","year":"2002","journal-title":"Anal Chem"},{"key":"10.1016\/j.eimc.2015.03.015_bib1095","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/1471-2334-11-336","article-title":"Clinical effectiveness of rapid tests for methicillin resistant Staphylococcus aureus (MRSA) in hospitalized patients: a systematic review","volume":"11","author":"Polisena","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1128\/JCM.01884-08","article-title":"Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA\/SA skin and soft tissue and blood culture assays","volume":"47","author":"Wolk","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2015.03.015_bib1105","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1128\/JCM.02179-08","article-title":"Evaluation of the BD GeneOhm StaphSR assay for detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from spiked positive blood culture bottles","volume":"47","author":"Grobner","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2015.03.015_bib1110","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/JCM.00232-07","article-title":"Evaluation of three molecular assays for rapid identification of methicillin-resistant Staphylococcus aureus","volume":"45","author":"Francois","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2015.03.015_bib1115","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/JCM.01988-10","article-title":"High proportion of wrongly identified methicillin-resistant Staphylococcus aureus carriers by use of a rapid commercial PCR assay due to presence of staphylococcal cassette chromosome element lacking the mecA gene","volume":"49","author":"Blanc","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2015.03.015_bib1120","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10096-009-0723-7","article-title":"Rapid detection of Staphylococcus aureus bacteremia and methicillin resistance by real-time PCR in whole blood samples","volume":"28","author":"Wellinghausen","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1125","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1086\/656623","article-title":"An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus\/S. aureus blood culture test in patients with S. aureus bacteremia","volume":"51","author":"Bauer","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/jac\/dkl146","article-title":"Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures","volume":"58","author":"Forrest","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/JCM.06169-11","article-title":"Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia","volume":"50","author":"Frye","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2015.03.015_bib1140","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/424520","article-title":"Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results","volume":"39","author":"Bouza","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/jac\/dkp406","article-title":"Factors and outcomes associated with physicians\u2019 adherence to recommendations of infectious disease consultations for inpatients","volume":"65","author":"Sellier","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1150","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/514686","article-title":"Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients","volume":"27","author":"Fowler","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1155","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cid\/cis889","article-title":"Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus Bacteremia","volume":"56","author":"Forsblom","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1160","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.amjmed.2010.01.015","article-title":"The value of infectious diseases consultation in Staphylococcus aureus bacteremia","volume":"123","author":"Honda","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1165","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/cid\/cit499","article-title":"Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia","volume":"57","author":"Lopez-Cortes","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1170","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s15010-014-0633-1","article-title":"Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital","volume":"42","author":"Borde","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.eimc.2015.03.015_bib1175","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jinf.2009.07.015","article-title":"Mortality of S. aureus bacteremia and infectious diseases specialist consultation \u2013 a study of 521 patients in Germany","volume":"59","author":"Rieg","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib1180","unstructured":"International Standard ISO 20776-1. Clinical laboratory testing and in vitro diagnostic test systems. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices. first ed. Geneva, Switzerland; 2006."},{"key":"10.1016\/j.eimc.2015.03.015_bib1185","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0; 2014 [20 June 2014]."},{"key":"10.1016\/j.eimc.2015.03.015_bib1190","unstructured":"Clinical and Laboratory Standard Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Twenty-fourth informational supplement. CLSI document M100-S24. Clinical and Laboratory Standards Institute W, PA; 2014."},{"key":"10.1016\/j.eimc.2015.03.015_bib1195","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M07-A9. Clinical and Laboratory Standards Institute W, PA, 9th ed.; 2012."},{"key":"10.1016\/j.eimc.2015.03.015_bib1200","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1473-3099(11)70126-8","article-title":"Methicillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study","volume":"11","author":"Garcia-Alvarez","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1205","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/jac\/dkp319","article-title":"Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals","volume":"64","author":"Sader","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1210","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis","volume":"54","author":"van Hal","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimc.2015.03.015_bib1220","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jac\/47.4.399","article-title":"A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital","volume":"47","author":"Wootton","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1225","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1128\/AAC.49.7.2687-2692.2005","article-title":"Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function","volume":"49","author":"Sakoulas","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1230","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(13)61219-2","article-title":"First case of infection with vancomycin-resistant Staphylococcus aureus in Europe","volume":"382","author":"Melo-Cristino","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2015.03.015_bib1235","series-title":"Present situation of antimicrobial resistance of Staphylococcus in Spain (2010): seventh nationwide prevalence study and emerging resistance to linezolid. 21st European congress of clinical microbiology and infectious diseases","year":"2011"},{"key":"10.1016\/j.eimc.2015.03.015_bib1240","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/jac\/dkt541","article-title":"Zyvox(R) Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004\u201312)","volume":"69","author":"Mendes","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1245","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1128\/AAC.00616-09","article-title":"Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006","volume":"53","author":"Sader","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1250","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/423841","article-title":"Antimicrobial resistance to linezolid","volume":"39","author":"Meka","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1255","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1086\/428616","article-title":"Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia","volume":"40","author":"Mangili","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1260","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1086\/520655","article-title":"Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus","volume":"45","author":"Boucher","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1265","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1086\/650574","article-title":"Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus","volume":"50","author":"Morales","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1270","series-title":"Eradication of an outbreak of linezolid-resistant methicillin-resistant Staphylococcus aureus in a post-surgical intensive care unit. Abstract K-238. 51st interscience conference on antimicrobial agents and chemotherapy","year":"2011"},{"key":"10.1016\/j.eimc.2015.03.015_bib1275","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1086\/605555","article-title":"Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries","volume":"49","author":"Ammerlaan","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1280","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/dkl006","article-title":"Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome","volume":"57","author":"Fang","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1285","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archinte.160.7.1001","article-title":"Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia","volume":"160","author":"Roghmann","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1290","doi-asserted-by":"crossref","first-page":"e11432","DOI":"10.1371\/journal.pone.0011432","article-title":"Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study","volume":"5","author":"Schweizer","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.eimc.2015.03.015_bib1295","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.diagmicrobio.2005.02.007","article-title":"Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia","volume":"52","author":"Lodise","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1300","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s15010-010-0059-3","article-title":"Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia","volume":"38","author":"Hanses","year":"2010","journal-title":"Infection"},{"key":"10.1016\/j.eimc.2015.03.015_bib1305","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1086\/374621","article-title":"Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections","volume":"187","author":"Laupland","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1310","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/jac\/dkq373","article-title":"Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia","volume":"65","author":"Paul","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1315","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jinf.2008.11.003","article-title":"Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant Staphylococcus aureus","volume":"58","author":"Rodriguez-Bano","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib1320","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1325","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1469-0691.2009.02934.x","article-title":"Case\u2013control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia","volume":"16","author":"Marchaim","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib1330","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/01.CCM.0000227655.41566.3E","article-title":"Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment","volume":"34","author":"Schramm","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1335","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1086\/375057","article-title":"Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia","volume":"36","author":"Lodise","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1340","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/519283","article-title":"A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients","volume":"45","author":"McGregor","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1345","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1086\/605556","article-title":"What is inadequate antibacterial therapy?","volume":"49","author":"Moellering","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1350","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/377540","article-title":"Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci","volume":"37","author":"Kim","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1355","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e31822f0b54","article-title":"Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: secular trends over 19 years at a university hospital","volume":"90","author":"Gasch","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eimc.2015.03.015_bib1360","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF02026134","article-title":"Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus","volume":"13","author":"Pujol","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1365","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1469-0691.2006.01589.x","article-title":"Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000","volume":"13","author":"Benfield","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib1370","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States","volume":"298","author":"Klevens","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2015.03.015_bib1375","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhin.2007.03.015","article-title":"Predictive factors of meticillin resistance among patients with Staphylococcus aureus bloodstream infections at hospital admission","volume":"66","author":"Manzur","year":"2007","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib1380","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jac\/dkh107","article-title":"Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains","volume":"53","author":"Tacconelli","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1385","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/cid\/cit546","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections among patients on chronic dialysis in the United States, 2005\u20132011","volume":"57","author":"Nguyen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1390","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1469-0691.2006.01622.x","article-title":"Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients","volume":"13","author":"Greiner","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib1395","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1001\/jama.293.24.3012","article-title":"Staphylococcus aureus endocarditis: a consequence of medical progress","volume":"293","author":"Fowler","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2015.03.015_bib1400","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2015.03.015_bib1405","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ajcp\/74.5.645","article-title":"Determination of tolerance to antibiotic bactericidal activity on Kirby\u2013Bauer susceptibility plates","volume":"74","author":"Peterson","year":"1980","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.eimc.2015.03.015_bib1410","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/archinte.1979.03630460058018","article-title":"Serious staphylococcal infections with strains tolerant to bactericidal antibiotics","volume":"139","author":"Denny","year":"1979","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1415","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9343(86)90180-4","article-title":"Relationship of staphylococcal tolerance, teichoic acid antibody, and serum bactericidal activity to therapeutic outcome in Staphylococcus aureus bacteremia","volume":"81","author":"Rahal","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1420","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1469-0691.2010.03425.x","article-title":"Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?","volume":"17","author":"Paul","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib1425","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1128\/AAC.34.6.1227","article-title":"Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users","volume":"34","author":"Small","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1430","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/jac\/dkl355","article-title":"Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis","volume":"58","author":"Fernandez Guerrero","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1435","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","article-title":"Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eimc.2015.03.015_bib1440","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00365540500372846","article-title":"Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome","volume":"38","author":"Khatib","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1445","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5694\/j.1326-5377.2009.tb02841.x","article-title":"Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand","volume":"191","author":"Turnidge","year":"2009","journal-title":"Med J Aust"},{"key":"10.1016\/j.eimc.2015.03.015_bib1450","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/AAC.00700-07","article-title":"Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"52","author":"Kim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1455","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1086\/510386","article-title":"Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"44","author":"Stryjewski","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1460","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/313440","article-title":"Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms","volume":"29","author":"Gonzalez","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1465","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1470","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jac\/dkl017","article-title":"Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK","volume":"57","author":"Gemmell","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1475","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/AAC.35.1.79","article-title":"Failure of treatment with teicoplanin at 6 milligrams\/kilogram\/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon","volume":"35","author":"Gilbert","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.eimc.2015.03.015_bib1480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0924-8579(94)90049-3","article-title":"A critical review of the dosage of teicoplanin in Europe and the USA","volume":"4","author":"Wilson","year":"1994","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2015.03.015_bib1485","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1128\/AAC.00341-09","article-title":"Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis","volume":"53","author":"Svetitsky","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1490","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1128\/AAC.00738-06","article-title":"Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria","volume":"51","author":"Mortin","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1495","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1128\/AAC.00102-08","article-title":"Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations","volume":"52","author":"Rose","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1500","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/jac\/dkn439","article-title":"Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic\/pharmacodynamic model with simulated endocardial vegetations","volume":"63","author":"Leonard","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1505","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1128\/AAC.00510-07","article-title":"Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus","volume":"52","author":"Marco","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1510","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cid\/cir764","article-title":"Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case\u2013control study","volume":"54","author":"Moore","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1515","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1473-3099(09)70200-2","article-title":"Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions","volume":"9","author":"Moise","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1520","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/AAC.00101-07","article-title":"Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1525","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/AAC.00348-09","article-title":"Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus","volume":"54","author":"Joukhadar","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1530","first-page":"118","article-title":"Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis","volume":"88","author":"Sande","year":"1976","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1535","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1128\/AAC.49.7.2735-2745.2005","article-title":"Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations","volume":"49","author":"Tsuji","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1540","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1128\/AAC.22.5.903","article-title":"Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains","volume":"22","author":"Watanakunakorn","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1545","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1128\/AAC.41.11.2497","article-title":"Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model","volume":"41","author":"Houlihan","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1550","doi-asserted-by":"crossref","first-page":"496","DOI":"10.7326\/0003-4819-97-4-496","article-title":"Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study","volume":"97","author":"Korzeniowski","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1555","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1161\/01.CIR.0000153812.64956.EF","volume":"111","author":"Baddour","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.eimc.2015.03.015_bib1560","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/597031","article-title":"Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic","volume":"48","author":"Cosgrove","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1565","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-125-12-199612150-00005","article-title":"Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial","volume":"125","author":"Ribera","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1570","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1575","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jac\/32.2.325","article-title":"Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination","volume":"32","author":"Goetz","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1580","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/cid\/cir340","article-title":"Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding","volume":"53","author":"Dhand","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1585","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1128\/AAC.06449-11","article-title":"High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis","volume":"56","author":"Miro","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1590","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1128\/AAC.00799-13","article-title":"Daptomycin in vitro activity against methicillin-resistant Staphylococcus aureus is enhanced by d-cycloserine in a mechanism associated with a decrease in cell surface charge","volume":"57","author":"Gasch","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1595","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2796.2005.01598.x","article-title":"Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients","volume":"259","author":"Ruotsalainen","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1600","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/AAC.29.4.611","article-title":"Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus","volume":"29","author":"Hackbarth","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1605","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archinte.168.8.805","article-title":"Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature","volume":"168","author":"Perlroth","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1610","first-page":"92","article-title":"Guidelines for the treatment of short-term intravascular catheter-related infections in adults; SEIMC-SEMICYUC Consensus Conference","volume":"22","author":"Leon","year":"2004","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2015.03.015_bib1615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1620","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0002-9343(90)90290-T","article-title":"Staphylococcus aureus bacteremia in patients with Hickman catheters","volume":"89","author":"Dugdale","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1625","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archinte.1995.00430110069007","article-title":"Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters","volume":"155","author":"Malanoski","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1630","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1586\/14787210.2014.863148","article-title":"Antibiotic-lock therapy: a clinical viewpoint","volume":"12","author":"Fernandez-Hidalgo","year":"2014","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.eimc.2015.03.015_bib1635","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1473-3099(13)70266-4","article-title":"Management of infections related to totally implantable venous-access ports: challenges and perspectives","volume":"14","author":"Lebeaux","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1640","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jac\/dkl103","article-title":"Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study","volume":"57","author":"Fernandez-Hidalgo","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1645","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/jac\/dkl318","article-title":"Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy","volume":"58","author":"Fortun","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1650","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.ajkd.2007.04.014","article-title":"Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report","volume":"50","author":"Maya","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1655","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/ndt\/gfh041","article-title":"Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen","volume":"19","author":"Poole","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.eimc.2015.03.015_bib1660","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MD.0b013e318289ff1e","article-title":"Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates","volume":"92","author":"Chong","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eimc.2015.03.015_bib1665","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1086\/427806","article-title":"Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia","volume":"40","author":"Fowler","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1670","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ahj.2003.09.018","article-title":"Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S. aureus and methicillin-resistant S. aureus bacteremia","volume":"147","author":"Abraham","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.eimc.2015.03.015_bib1675","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0735-1097(97)00250-7","article-title":"Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients","volume":"30","author":"Fowler","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.eimc.2015.03.015_bib1680","first-page":"23","article-title":"Importance of transesophageal echocardiography in the evaluation of Staphylococcus aureus bacteremia","volume":"14","author":"Sullenberger","year":"2005","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/cir320","article-title":"Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia","volume":"53","author":"Kaasch","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1690","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MD.0b013e318294a710","article-title":"Echocardiography is dispensable in uncomplicated Staphylococcus aureus bacteremia","volume":"92","author":"Khatib","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eimc.2015.03.015_bib1695","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10096-003-1041-0","article-title":"Management of catheter-related Staphylococcus aureus bacteremia: when may sonographic study be unnecessary?","volume":"22","author":"Pigrau","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1700","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cid\/cir305","article-title":"Is transesophageal echocardiography dispensable in hospital-acquired Staphylococcus aureus bacteremia?","volume":"53","author":"Soriano","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1705","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia","volume":"163","author":"Fowler","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1710","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/clinids\/14.1.75","article-title":"Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review","volume":"14","author":"Raad","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1715","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/eurheartj\/eht274","article-title":"Cardiac imaging in infectious endocarditis","volume":"35","author":"Bruun","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.eimc.2015.03.015_bib1720","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s00259-013-2376-0","article-title":"The value of 18F-FDG PET\/CT in diagnosing infectious endocarditis","volume":"40","author":"Kouijzer","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.eimc.2015.03.015_bib1725","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.jacc.2013.01.092","article-title":"Positron emission tomography\/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion","volume":"61","author":"Saby","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.eimc.2015.03.015_bib1730","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/jac\/dkt108","article-title":"Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis","volume":"68","author":"Nissen","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1735","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1471-2334-11-279","article-title":"Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia","volume":"11","author":"Schweizer","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1740","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1128\/AAC.00485-11","article-title":"Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?","volume":"55","author":"Lee","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1745","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1128\/AAC.00757-12","article-title":"Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremia","volume":"56","author":"Han","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1750","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/cid\/cit112","article-title":"Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1mg\/L: a matched cohort study","volume":"56","author":"Murray","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1755","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jac\/dki355","article-title":"Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies","volume":"56","author":"Shorr","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1760","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1473-3099(07)70312-2","article-title":"Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials","volume":"8","author":"Falagas","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1765","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1086\/595686","article-title":"Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study","volume":"48","author":"Wilcox","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1770","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1128\/AAC.01021-12","article-title":"Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study","volume":"57","author":"Chong","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1775","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/1097-0142(19840115)53:2<219::AID-CNCR2820530206>3.0.CO;2-2","article-title":"Indwelling venous access catheters in patients with acute leukemia","volume":"53","author":"Reilly","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.eimc.2015.03.015_bib1780","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-119-4-199308150-00010","article-title":"Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis","volume":"119","author":"Jernigan","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1785","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/infdis\/169.2.350","article-title":"A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of Gram-positive bacteremia in patients with cancer","volume":"169","author":"Rolston","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1790","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1473-3099(10)70285-1","article-title":"Clinical management of Staphylococcus aureus bacteraemia","volume":"11","author":"Thwaites","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1795","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jinf.2013.10.015","article-title":"Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies","volume":"68","author":"Kaasch","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib1800","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/jac\/dks408","article-title":"Prioritizing echocardiography in Staphylococcus aureus bacteraemia","volume":"68","author":"Joseph","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1805","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archinte.162.1.25","article-title":"Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases","volume":"162","author":"Jensen","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1810","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/clinids\/9.5.891","article-title":"Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia","volume":"9","author":"Mylotte","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1815","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.CCM.0B013E3181611F914","article-title":"Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia","volume":"36","author":"Crowley","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1820","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1086\/318704","article-title":"Infection of orthopedic prostheses after Staphylococcus aureus bacteremia","volume":"32","author":"Murdoch","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1825","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinf.2011.05.005","article-title":"Periprosthetic joint infection following Staphylococcus aureus bacteremia","volume":"63","author":"Sendi","year":"2011","journal-title":"J Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib1830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e318194da65","article-title":"Endocarditis caused by Staphylococcus aureus: a reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome","volume":"88","author":"Fernandez Guerrero","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eimc.2015.03.015_bib1835","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/MD.0b013e31824d7ed2","article-title":"Metastatic infectious disease and clinical outcome in Staphylococcus aureus and Streptococcus species bacteremia","volume":"91","author":"Vos","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eimc.2015.03.015_bib1840","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.md.0000091185.93122.40","article-title":"A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eimc.2015.03.015_bib1845","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1093\/jac\/dku082","article-title":"Staphylococcus aureus bacteraemia in a UK tertiary referral centre: a \u2018transoesophageal echocardiogram for all\u2019 policy","volume":"69","author":"Holden","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1850","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/cid\/ciu183","article-title":"Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis","volume":"58","author":"Cervera","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1855","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1128\/AAC.02192-12","article-title":"Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant beta-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment","volume":"57","author":"Moise","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1860","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/dkl044","article-title":"The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials","volume":"57","author":"Falagas","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1865","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1745-6215-13-241","article-title":"Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial","volume":"13","author":"Thwaites","year":"2012","journal-title":"Trials"},{"issue":"Suppl. 1","key":"10.1016\/j.eimc.2015.03.015_bib1870","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1093\/cid\/cit614","article-title":"Methicillin-resistant Staphylococcus aureus therapy: past, present, and future","volume":"58","author":"Rodvold","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1875","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets","volume":"52","author":"Kullar","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1880","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/cir078","article-title":"Vancomycin: we can\u2019t get there from here","volume":"52","author":"Patel","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1885","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01568-12","article-title":"Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter","volume":"57","author":"van Hal","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1890","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MCC.0b013e3283578968","article-title":"Does resistance in severe infections caused by methicillin-resistant Staphylococcus aureus give you the \u2018creeps\u2019?","volume":"18","author":"Brink","year":"2012","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.eimc.2015.03.015_bib1895","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/phar.1220","article-title":"Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"33","author":"Kullar","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.eimc.2015.03.015_bib1900","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijantimicag.2011.03.006","article-title":"Daptomycin: evaluation of a high-dose treatment strategy","volume":"38","author":"Wu","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2015.03.015_bib1905","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkt396","article-title":"Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin","volume":"69","author":"Gasch","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1910","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/AAC.01525-12","article-title":"beta-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives","volume":"56","author":"Mehta","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1915","first-page":"619321","article-title":"Antibiotic combinations with daptomycin for treatment of Staphylococcus aureus infections","volume":"2011","author":"Nadrah","year":"2011","journal-title":"Chemother Res Pract"},{"key":"10.1016\/j.eimc.2015.03.015_bib1920","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00502-12","article-title":"Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics","volume":"56","author":"Berti","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1925","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/AAC.00487-10","article-title":"Daptomycin\u2013oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the seesaw effect)","volume":"54","author":"Yang","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1930","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0732-8893(92)90045-U","article-title":"In vivo activity of the combination of daptomycin and fosfomycin compared with daptomycin alone against a strain of Enterococcus faecalis with high-level gentamicin resistance in the rat endocarditis model","volume":"15","author":"Rice","year":"1992","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1935","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/AAC.01570-12","article-title":"Fosfomycin-daptomycin and other fosfomycin combinations as alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus","volume":"57","author":"Garrigos","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1940","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2334-11-152","article-title":"High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: case report","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1945","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.30.6.917","article-title":"Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus","volume":"30","author":"Utsui","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. B","key":"10.1016\/j.eimc.2015.03.015_bib1950","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/jac\/14.suppl_B.277","article-title":"Treatment of severe staphylococcal infections with cefotaxime and fosfomycin in combination","volume":"14","author":"Portier","year":"1984","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib1955","first-page":"2135","article-title":"Fosfomycin\u2013cefotaxime combination in severe staphylococcal infections in newborn infants","volume":"14","author":"Gouyon","year":"1985","journal-title":"Presse Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1960","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10096-009-0833-2","article-title":"Fosfomycin: an old, new friend?","volume":"29","author":"Popovic","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1965","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/cid\/ciu580","article-title":"Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multi-center clinical trial","volume":"59","author":"Del Rio","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1970","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1186\/cc10313","article-title":"C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study","volume":"15","author":"Povoa","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.eimc.2015.03.015_bib1975","doi-asserted-by":"crossref","first-page":"e46389","DOI":"10.1371\/journal.pone.0046389","article-title":"Persistent catheter-related Staphylococcus aureus bacteremia after catheter removal and initiation of antimicrobial therapy","volume":"7","author":"Park","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.eimc.2015.03.015_bib1980","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/595738","article-title":"Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model","volume":"199","author":"Xiong","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib1985","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7326\/0003-4819-93-6-832","article-title":"Intravenous followed by oral antimicrobial therapy for staphylococcal endocarditis","volume":"93","author":"Parker","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib1990","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.inf.0000073163.37519.ee","article-title":"Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children","volume":"22","author":"Martinez-Aguilar","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2015.03.015_bib1995","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1469-0691.2006.01585.x","article-title":"Linezolid therapy for infective endocarditis","volume":"13","author":"Munoz","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib2000","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2106\/JBJS.G.00838","article-title":"Direct demonstration of viable Staphylococcus aureus biofilms in an infected total joint arthroplasty. A case report","volume":"90","author":"Stoodley","year":"2008","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.eimc.2015.03.015_bib2005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/emmm.201000115","article-title":"Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection","volume":"3","author":"Tuchscherr","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib2010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0002-9343(96)00070-8","article-title":"Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy","volume":"101","author":"Heldman","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib2015","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/424506","article-title":"A randomized clinical trial to compare fleroxacin\u2013rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection","volume":"39","author":"Schrenzel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib2020","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/521894","article-title":"Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis","volume":"45","author":"Nijland","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib2025","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1128\/AAC.01621-06","article-title":"Effects of rifampin and multidrug resistance gene polymorphism on concentrations of moxifloxacin","volume":"51","author":"Weiner","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib2030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijantimicag.2008.09.011","article-title":"Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin","volume":"33","author":"Viale","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2015.03.015_bib2035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.01081-09","article-title":"Continuous clindamycin infusion, an innovative approach to treating bone and joint infections","volume":"54","author":"Zeller","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib2040","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1128\/AAC.45.11.3238-3241.2001","article-title":"Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients","volume":"45","author":"Ribera","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib2045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/0091270010366445","article-title":"Unexpected effect of rifampin on the pharmacokinetics of linezolid: in silico and in vitro approaches to explain its mechanism","volume":"51","author":"Gandelman","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.eimc.2015.03.015_bib2050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jac\/dkl219","article-title":"Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence","volume":"58","author":"Falagas","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib2055","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-117-5-390","article-title":"Trimethoprim\u2013sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection","volume":"117","author":"Markowitz","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib2060","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","article-title":"Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study","volume":"169","author":"Murdoch","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib2065","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archinternmed.2011.1027","article-title":"Increasing US rates of endocarditis with Staphylococcus aureus: 1999\u20132008","volume":"172","author":"Federspiel","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib2070","doi-asserted-by":"crossref","first-page":"586","DOI":"10.7326\/0003-4819-150-9-200905050-00004","article-title":"Health care-associated native valve endocarditis: importance of non-nosocomial acquisition","volume":"150","author":"Benito","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib2075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/431979","article-title":"Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database","volume":"41","author":"Miro","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.eimc.2015.03.015_bib2080","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.1086\/598187","article-title":"Patients at risk of complications of Staphylococcus aureus bloodstream infection","volume":"48","author":"del Rio","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib2085","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10096-007-0458-2","article-title":"Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis","volume":"27","author":"Hill","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib2090","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1086\/314712","article-title":"Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients","volume":"179","author":"Fowler","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib2095","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-115-9-674","article-title":"Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis","volume":"115","author":"Levine","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2015.03.015_bib2100","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/cid\/cit560","article-title":"The empirical combination of vancomycin and a beta-lactam for Staphylococcal bacteremia","volume":"57","author":"McConeghy","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib2105","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1592\/phco.31.5.441","article-title":"Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20mg\/L suggested by the vancomycin consensus guidelines","volume":"31","author":"Kullar","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.eimc.2015.03.015_bib2110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/AAC.01586-12","article-title":"Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic\/pharmacodynamic model","volume":"57","author":"Werth","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib2115","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/jac\/dku085","article-title":"Salvage treatment of methicillin-resistant staphylococcal endocarditis with ceftaroline: a multicentre observational study","volume":"69","author":"Tattevin","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.eimc.2015.03.015_bib2120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0213-005X(14)70158-2","article-title":"Role of ceftaroline fosamil in the treatment of bacteremia and infectious endocarditis","volume":"32","author":"Almirante","year":"2014","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2015.03.015_bib2125","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","volume":"30","author":"Habib","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.eimc.2015.03.015_bib2130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0891-5520(20)30507-9","article-title":"Endocarditis due to coagulase-negative staphylococci. Microbiologic, epidemiologic, and clinical considerations","volume":"7","author":"Whitener","year":"1993","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.eimc.2015.03.015_bib2135","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1128\/AAC.00455-10","article-title":"Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm","volume":"54","author":"Parra-Ruiz","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib2140","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1128\/AAC.00458-08","article-title":"Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infection","volume":"52","author":"Murillo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib2145","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1128\/AAC.00051-09","article-title":"Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus","volume":"53","author":"Miro","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib2150","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1001\/jama.2012.497","article-title":"Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices","volume":"307","author":"Athan","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2015.03.015_bib2155","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1378\/chest.124.4.1451","article-title":"Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome","volume":"124","author":"del Rio","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.eimc.2015.03.015_bib2160","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/AAC.01602-07","article-title":"Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib2165","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1128\/AAC.01563-13","article-title":"High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the international collaboration on endocarditis","volume":"57","author":"Carugati","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib2170","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIRCULATIONAHA.112.001170","article-title":"Enterococcus faecalis infective endocarditis: a pilot study of the relationship between duration of gentamicin treatment and outcome","volume":"127","author":"Dahl","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.eimc.2015.03.015_bib2175","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1128\/AAC.00797-12","article-title":"Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity","volume":"56","author":"Rose","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib2180","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.clinthera.2014.05.061","article-title":"Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline","volume":"36","author":"Sakoulas","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.eimc.2015.03.015_bib2185","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.eimc.2015.03.015_bib2190","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/eurheartj\/ehs379","article-title":"Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis","volume":"34","author":"Lopez","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.eimc.2015.03.015_bib2195","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1001\/jama.1995.03530210060032","article-title":"Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association","volume":"274","author":"Wilson","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2015.03.015_bib2200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1086\/430908","article-title":"Bacteriological outcome after valve surgery for active infective endocarditis: implications for duration of treatment after surgery","volume":"41","author":"Morris","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib2205","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1586\/eri.10.49","article-title":"Current management of bloodstream infections","volume":"8","author":"Rodriguez-Bano","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.eimc.2015.03.015_bib2210","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/529190","article-title":"Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia","volume":"46","author":"Jenkins","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib2215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MD.0b013e3181b8fccb","article-title":"Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia","volume":"88","author":"Lahey","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eimc.2015.03.015_bib2220","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1469-0691.2010.03156.x","article-title":"Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia","volume":"16","author":"Nagao","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib2225","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1007\/s10096-012-1585-y","article-title":"Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia","volume":"31","author":"Robinson","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2015.03.015_bib2230","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jinf.2005.01.011","article-title":"The role of transthoracic echocardiography in excluding left sided infective endocarditis in Staphylococcus aureus bacteraemia","volume":"51","author":"Van Hal","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.eimc.2015.03.015_bib2235","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib2240","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijantimicag.2012.10.015","article-title":"Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock","volume":"41","author":"Zelenitsky","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2015.03.015_bib2245","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/AAC.01485-12","article-title":"Vancomycin AUC\/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia","volume":"57","author":"Holmes","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2015.03.015_bib2250","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijantimicag.2013.10.017","article-title":"Area under the concentration\u2013time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia","volume":"43","author":"Jung","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2015.03.015_bib2255","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.clinthera.2013.05.018","article-title":"Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy","volume":"35","author":"Joo","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.eimc.2015.03.015_bib2260","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.ijid.2012.08.005","article-title":"High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis","volume":"17","author":"Jacob","year":"2013","journal-title":"Int J Infect Dis"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X15001251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X15001251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T22:38:18Z","timestamp":1668638298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X15001251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":253,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0213005X15001251"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2015.03.015","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2015.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Espa\u00f1a, S.L.U. y Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}